Alpha Cognition (ACOG) Cash from Investing Activities (2025)

Alpha Cognition's (ACOG) quarterly Cash from Investing Activities came in at -$147523.0 in Q4 2025, down 98.33% quarter-over-quarter from -$74381.0 in Q3 2025.

Alpha Cognition (ACOG) Cash from Investing Activities (2025) Analysis & Trends

Alpha Cognition's Cash from Investing Activities history runs 1 years deep, the most recent figure standing at -$147523.0 for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities changed N/A year-over-year to -$147523.0 in Q4 2025; TTM through Dec 2025 was -$293489.0, a N/A change from a year earlier, with the FY2025 full-year figure at -$293489.0, down 999.17% from the prior year.
  • Cash from Investing Activities declined to -$147523.0 in Q4 2025 per ACOG's latest filing, from -$74381.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$8315.0 in Q2 2025 and bottomed at -$147523.0 in Q4 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Oculis Holding AG 66,921.77 Bn 66,921.49 Bn - -
2 Nanobiotix 1,924.26 Bn 1,924.20 Bn - -
3 Akari Therapeutics 975.59 Bn 975.59 Bn - -
4 BeOne Medicines 471.47 Bn 466.67 Bn 1.35 Bn -45.51 Mn
5 Vertex Pharmaceuticals 121.76 Bn 114.52 Bn 2.59 Bn -431.90 Mn
6 Regeneron Pharmaceuticals 69.90 Bn 61.15 Bn 3.31 Bn -428.90 Mn
7 Belite Bio 62.83 Bn 62.83 Bn - -
8 Argenx Se 55.77 Bn 50.59 Bn 1.41 Bn -
9 Revolution Medicines 37.45 Bn 37.45 Bn - 172.62 Mn
10 Alpha Cognition 150.99 Mn 84.89 Mn 2.61 Mn -147,523.00

Historic Data

Download Data
DateValue
Dec 31, 2025 -147,523.00
Dec 31, 2025 -147,523.00
Sep 30, 2025 -74,381.00
Sep 30, 2025 -74,381.00
Jun 30, 2025 -8,315.00
Jun 30, 2025 -8,315.00
Mar 31, 2025 -63,270.00
Mar 31, 2025 -63,270.00